{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:36:20Z","timestamp":1789054580900,"version":"build-2803163510"},"reference-count":15,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2021]]},"DOI":"10.5761\/atcs.oa.20-00364","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T22:09:27Z","timestamp":1622153367000},"page":"317-321","source":"Crossref","is-referenced-by-count":5,"title":["The Efficacy and Renal Protective Effect of Tolvaptan in Chronic Kidney Disease Patients after Open-Heart Surgery"],"prefix":"10.5761","volume":"27","author":[{"given":"Yasuhiro","family":"Futamura","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Aichi Medical University Hospital, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Watanuki","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Aichi Medical University Hospital, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaho","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Aichi Medical University Hospital, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Aichi Medical University Hospital, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Aichi Medical University Hospital, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Yeo KK, Li Z, Yeun JY, et al. Severity of chronic kidney disease as a risk factor for operative mortality in nonemergent patients in the California coronary artery bypass graft surgery outcomes reporting program. Am J Cardiol 2008; 101: 1269\u201374.","DOI":"10.1016\/j.amjcard.2008.01.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tominaga N, Kida K, Matsumoto N, et al. Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics\/pharmacodynamics study. Clin Nephrol 2015; 84: 29\u201338.","DOI":"10.5414\/CN108457"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tan SI, Brewster DJ, Horrigan D, et al. Pharmacological and non-surgical renal protective strategies for cardiac surgery patients undergoing cardiopulmonary bypass: a systematic review. ANZ J Surg 2019; 89: 296\u2013302.","DOI":"10.1111\/ans.14800"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364: 797\u2013805.","DOI":"10.1056\/NEJMoa1005419"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Onogawa T, Sakamoto Y, Nakamura S, et al. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure. Cardiovasc Drugs Ther 2011; 25: 67\u201376.","DOI":"10.1007\/s10557-011-6350-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Matsuyama K, Koizumi N, Nishibe T, et al. Effects of short-term administration of tolvaptan after open heart surgery. Int J Cardiol 2016; 220: 192\u20135.","DOI":"10.1016\/j.ijcard.2016.06.156"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nishi H, Toda K, Miyagawa S, et al. Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial. Surg Today 2015; 45: 1542\u201351.","DOI":"10.1007\/s00595-015-1251-y"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kishimoto Y, Nakamura Y, Harada S, et al. Can tolvaptan protect renal function in the early postoperative period of cardiac surgery? - results of a single-center randomized controlled study. Circ J 2018; 82: 999\u20131007.","DOI":"10.1253\/circj.CJ-17-0967"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yamada M, Nishi H, Sekiya N, et al. The efficacy of tolvaptan in the perioperative management of chronic kidney disease patients undergoing open-heart surgery. Surg Today 2017; 47: 498\u2013505.","DOI":"10.1007\/s00595-016-1406-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982\u201392.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Jiang W, Teng J, Xu J, et al. Dynamic predictive scores for cardiac surgery-associated acute kidney injury. J Am Heart Assoc 2016; 5: e003754.","DOI":"10.1161\/JAHA.116.003754"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Uemura Y, Shibata R, Takemoto K, et al. Safety and efficacy of long-term use of Tolvaptan in patients with heart failure and chronic kidney disease. Circ J 2017; 81: 1736\u20138.","DOI":"10.1253\/circj.CJ-17-0554"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sato E, Nakamura T, Amaha M, et al. Effect of tolvaptan in patients with chronic kidney disease due to diabetic nephropathy with heart failure. Int Heart J 2014; 55: 533\u20138.","DOI":"10.1536\/ihj.14-190"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) M\u00e5rtensson J, Bellomo R. Prevention of renal dysfunction in postoperative elderly patients. Curr Opin Crit Care 2014; 20: 451\u20139.","DOI":"10.1097\/MCC.0000000000000107"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Noguchi K, Tanaka M, Katayama I, et al. Efficacy of Tolvaptan in patients with volume overload after cardiac surgery. Heart Surg Forum 2015; 18: E232\u20136.","DOI":"10.1532\/hsf.1470"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/27\/5\/27_oa.20-00364\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T03:57:01Z","timestamp":1634961421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/27\/5\/27_oa.20-00364\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.20-00364","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"oa.20-00364"}}